Want to know if this job is worth applying to?
Acton, Massachusetts, United States
Hybrid
Job Summary
As the Manager, Commercial Analytics you will play a pivotal role in driving transformative commercial outcomes across global markets. You will leverage advanced analytics to deliver strategic insights, performance analysis, and market intelligence that shape executive decision making and commercial strategy across regions.Role Overview
At Insulet our mission is to improve the lives of people living with Diabetes. We do this through our amazing product, Omnipod. Want to put your true marketing skills to work and be part of establishing the Omnipod brand in the hearts and minds of consumers? Then join the Global Digital Marketing team! These days, customers increasingly expect experiences that are relevant, timely, and personalized. Regardless of what channel they are using to interact with us – whether it is on a computer, mobile, or some other device – we want to make sure we are meeting and surpassing expectations with interactions that are easy and delightful.
As the Manager, Commercial Analytics you will play a pivotal role in driving transformative commercial outcomes across global markets. You will leverage advanced analytics to deliver strategic insights, performance analysis, and market intelligence that shape executive decision making and commercial strategy across regions.
This role is ideal for an analytical thought partner and proactive strategist—someone who tailors insights to regional needs, fosters cross functional collaboration, and contributes to global commercial success through data driven decision-making.
Key Responsibilities
Education & Experience
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with insulin-requiring diabetes.
Insulet was founded in 2000 with the mission to improve the lives of people with diabetes and enable customers to enjoy simplicity, freedom, and healthier lives through innovative technology. The Company’s world headquarters and state-of-the-art automated manufacturing facility are located in Acton, Massachusetts with global offices in the U.K., France, Germany, Netherlands, Canada, Mexico, Australia, and the United Arab Emirates. Omnipod products are available in 24 countries around the world.
Insulet recently concluded its seventh consecutive year of 20% or more revenue growth, and more than doubled its intellectual property portfolio over the last year. Insulet is proud to be recognized as a 2022 Top Workplace USA; awarded Top Workplaces Cultural Excellence Award for remote work; recognized as a Great Place to Work® in four international locations in 2023; and ranked as one of America’s most responsible companies by Newsweek. For more information, visit: insulet.com and omnipod.com.
This position is eligible for hybrid working arrangements and requires on-site work from an Insulet office.
#LI-Hybrid
Working at Insulet Corporation | Top Workplaces
Additional Information:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
